DexCom Inc (DXCM)

Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell

$83.00

Buy

$84.56

arrow-down$-0.32 (-0.38%)

Prices updated at 24 May 2025, 00:29 EDT
| Prices minimum 15 mins delay
|
Prices in USD
DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients.
NASDAQ
arrow-down-1%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Medical Devices
Chairman
Mr. Kevin R. Sayer, C.P.A.
CEO
Mr. Kevin R. Sayer, C.P.A.
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
10,300
Head office
6340 Sequence Drive
San Diego
United States
92121
mobile
+1 858 200-0200
letter
investorrelations@dexcom.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Ms. Renee D. Gala
Independent Director
-
Mr. Jacob S. Leach
President and Chief Operating Officer
0.68m
Mr. Kevin R. Sayer, C.P.A.
President, Chief Executive Officer and Chairman of the Board
1.16m
Mr. Mark G. Foletta
Lead Independent Director
-
Mr. Steven R. Altman
Independent Director
-
Mr. Nicholas Augustinos
Independent Director
-
Ms. Bridgette P. Heller
Independent Director
-
Mr. Jereme M. Sylvain
Executive Vice President, Chief Financial Officer and Principal Accounting Officer
0.61m
Mr. Richard A. Collins
Independent Director
-
Mr. Kyle Malady
Independent Director
-
Ms. Sadie M. Stern
Executive Vice President and Chief Human Resources Officer
0.54m
Mr. Michael J. Brown
Executive Vice President and Chief Legal Officer
0.60m
Ms. Rimma Driscoll
Independent Director
-

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
Vanguard Group Inc47,455,899
BlackRock Inc39,241,177
State Street Corp16,682,808
BlackRock Fund Advisors15,589,128
Capital Research and Management Company15,078,486

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
16 Dec 2024-
16 Dec 2024-
16 Dec 2024-
16 Dec 2024-
20 Nov 2024-
15 Nov 2024-
16 Sep 2024-
09 Sep 2024-
09 Sep 2024-
09 Sep 2024-
30 Aug 2024-
31 Jul 2024-
28 Jun 2024-
17 Jun 2024-
18 Jun 2024-
18 Jun 2024-
17 Jun 2024-
17 Jun 2024-
14 Jun 2024-
10 Jun 2024-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.